2m 2m 2m 2m 2m 2m 2m
Ultragenyx Pharm (RARE)
NASDAQ
$24.95+$0.04 (+0.16%)
Price as of Aug 03, 2026 8:56 AM EDT- $2.5BMarket Cap
- -12.41%1-Year Change
- BiotechnologyIndustry
Ultragenyx Pharm (RARE)
$24.95+$0.04 (+0.16%)
RARE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.91 | ||
Change | -$1.13 (-4.34%) | ||
Open | $25.95 | ||
High | $26.07 | ||
Low | $24.59 | ||
Previous Close | $26.04 | ||
Volume | 1,537,765 | ||
30-Day Average Volume | 1,889,388 | ||
1-Week Change | -7.40% | ||
1-Month Change | -25.40% | ||
1-Year Change | -12.41% | ||
3-Year Change | -42.23% | ||
5-Year Change | -68.80% | ||
Fundamentals | |||
Shares Outstanding | 98.5M | ||
Total Assets | $1.3B | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $89.0M | ||
Net Income | -$185.0M | ||
Free Cash Flow | -$198.0M | ||
EBIT | -$184.0M | ||
EBITDA | -$176.0M | ||
Net Working Capital | $332.0M | ||
EPS | -$1.84 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 26 | ||
P/B | -10 | ||
P/E | -14 | ||
PEG | 0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue